Givinostat
Givinostat (ITF-2357) is an orally bioavailable, pan-HDAC inhibitor that blocks STAT5 phosphorylation, demonstrating antitumor effects in crlf2-rearranged BCP-ALL models. Its anti-inflammatory properties, including suppression of TNF-α and IL-1β, and promotion of β-cell survival support research in leukemia, diabetes, and arthritis, as evidenced by in vitro and in vivo studies.
Product Specifications
CAS Number
497833-27-9
Product Name Alternative
ITF-2357, ITF2357, Givinostat
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Molecular Biology, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.56% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:4 mg/mL (9.49 mM) ; DMSO:160 mg/mL (379.6 mM)
Smiles
CCN (CC) Cc1ccc2cc (COC (=O) Nc3ccc (cc3) C (=O) NO) ccc2c1
Molecular Formula
C24H27N3O4
Molecular Weight
421.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![[Phe13, Tyr19]-MCH (Human, Mouse, Rat)](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Aurora-B, NT (AURKB, AIK2, AIM1, AIRK2, ARK2, STK1, STK12, STK5, Aurora kinase B, Aurora 1, Aurora- and IPL1-like midbody-associated protein 1, Aurora/IPL1-related kinase 2, STK-1, Serine/threonine-protein kinase 12, Serine/threonine-protein kinase 5, Ser